acyclovir

Generic: acyclovir

Labeler: alembic pharmaceuticals inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler alembic pharmaceuticals inc.
Dosage Form OINTMENT
Routes
CUTANEOUS
Active Ingredients

acyclovir 50 mg/g

Manufacturer
Alembic Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 62332-248
Product ID 62332-248_40ce38dc-e259-49e3-98e4-0f529b9ab17e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209000
Listing Expiration 2026-12-31
Marketing Start 2025-03-27

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62332248
Hyphenated Format 62332-248

Supplemental Identifiers

RxCUI
197312
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA209000 (source: ndc)
Routes
CUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (62332-248-05) / 5 g in 1 TUBE
  • 1 TUBE in 1 CARTON (62332-248-15) / 15 g in 1 TUBE
  • 1 TUBE in 1 CARTON (62332-248-30) / 30 g in 1 TUBE
source: ndc

Packages (3)

62332-248-05 1 TUBE in 1 CARTON (62332-248-05) / 5 g in 1 TUBE 62332-248-15 1 TUBE in 1 CARTON (62332-248-15) / 15 g in 1 TUBE 62332-248-30 1 TUBE in 1 CARTON (62332-248-30) / 30 g in 1 TUBE

Ingredients (1)

acyclovir (50 mg/g)

Linked Drug Pages (1)

Acyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["CUTANEOUS"], "spl_id": "40ce38dc-e259-49e3-98e4-0f529b9ab17e", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197312"], "spl_set_id": ["5adf2205-5493-4e7a-bf50-01f4eb661dd8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Alembic Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (62332-248-05)  / 5 g in 1 TUBE", "package_ndc": "62332-248-05", "marketing_start_date": "20250327"}, {"sample": false, "description": "1 TUBE in 1 CARTON (62332-248-15)  / 15 g in 1 TUBE", "package_ndc": "62332-248-15", "marketing_start_date": "20250327"}, {"sample": false, "description": "1 TUBE in 1 CARTON (62332-248-30)  / 30 g in 1 TUBE", "package_ndc": "62332-248-30", "marketing_start_date": "20250327"}], "brand_name": "Acyclovir", "product_id": "62332-248_40ce38dc-e259-49e3-98e4-0f529b9ab17e", "dosage_form": "OINTMENT", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "62332-248", "generic_name": "Acyclovir", "labeler_name": "Alembic Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "50 mg/g"}], "application_number": "ANDA209000", "marketing_category": "ANDA", "marketing_start_date": "20250327", "listing_expiration_date": "20261231"}